Conventional Interferon Therapy Response among Chronic HCV Patients in Khyber Pakhtunkhwa | OMICS International | Abstract
ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Conventional Interferon Therapy Response among Chronic HCV Patients in Khyber Pakhtunkhwa

Bashir Ahmad1 Sajid Ali1* Ijaz Ali2 Nourin Mahmood1 Shumaila Bashir3 Shoaib Nawaz4
1Centre for Biotechnology and Microbiology, University of Peshawar, Peshawar, Khyber Pakhtunkhwa, Pakistan
2Institute of Biotechnology and Genetic Engineering, Agricultural University, Peshawar, Khyber Pakhtunkhwa, Pakistan
3Departmet of Pharmacy, University of Peshawar, Peshawar, Khyber Pakhtunkhwa, Pakistan
4Department of Biotechnology, Kohat university of Science and Technology, Kohat, Khyber Pakhtunkhwa, Pakistan
Corresponding Author : Sajid Ali
Centre for Biotechnology and Microbiology
University of Peshawar, Peshawar
Khyber Pakhtunkhwa, Pakistan
E-mail: [email protected]
Received March 11, 2013; Accepted April 24, 2013; Published April 27, 2013
Citation: Ahmad B, Ali S, Ali I, Mahmood N, Bashir S, et al. (2013) Conventional Interferon Therapy Response among Chronic HCV Patients in Khyber Pakhtunkhwa. J Infect Dis Ther 1:104. doi: 10.4172/2332-0877.1000104
Copyright: © 2013 Ahmad B, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google


As Hepatitis C infection is the cause of hundreds of thousands of deaths worldwide including Pakistan. Different regions have different infection rates in Pakistan and hence different mortality. Khyber Pakhtunkhwa (KPK) is one of the main affected provinces of the country. Since Interferon (IFN) based therapy is used to eradicate the infection from the bodies of infected individuals. However information regarding treatment response in different population groups in case of chronic HCV patients is lacking. So it is aimed to investigate response rates of IFN and Ribavirin combination therapy in different districts of KPK.

A total of 198 anti-HCV and PCR positive patients were selected from district Swabi, 54 from Kohat and 89 from Bunir for conventional IFN therapy keeping in mind therapy exclusive criteria for patients. All the patients were given 3MIU thrice a week and 300-400 mg thrice a day, dose of conventional IFN and Ribavirin respectively. Therapy was continued for six months with repeated investigations of CBCs and LFTs during and at the end of course. PCR test was also repeated during (3 months) and at the end of treatment (6 months).
Out of total 341, selected patients for standard IFN- based therapy, 288 (81%) showed ETR while 53 (19%) did not show response. In different districts of KPK, the ETR rates were, 92% in district Swabi, 71% in Bunir and 80% in district Kohat. All these patients having positive ETR were negative for HCV RNA at the end of six months of conventional IFN therapy.
IFN therapy response varies among different population groups of KPK but the average response rate is good enough against HCV infection. This high response may be attributed to responsive genotypes prevalent in KPK.